Closeout of four phase II Vanguard trials and patient rollover into a large international phase III HIV clinical endpoint trial.
- DOI
- 10.1016/s0197-2456(00)00114-8
- Published
- 2001 Feb
- Container
- Controlled clinical trials
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s0197-2456-00-00114-8,
title = {Closeout of four phase II Vanguard trials and patient rollover into a large international phase III HIV clinical endpoint trial.},
author = {Tavel JA and Fosdick L and ESPRIT Vanguard Group. ESPRIT Executive Committee},
year = {2001},
journal = {Controlled clinical trials},
doi = {10.1016/s0197-2456(00)00114-8},
url = {https://doi.org/10.1016/s0197-2456(00)00114-8}
}RIS
TY - JOUR TI - Closeout of four phase II Vanguard trials and patient rollover into a large international phase III HIV clinical endpoint trial. AU - Tavel JA AU - Fosdick L AU - ESPRIT Vanguard Group. ESPRIT Executive Committee PY - 2001 JO - Controlled clinical trials DO - 10.1016/s0197-2456(00)00114-8 UR - https://doi.org/10.1016/s0197-2456(00)00114-8 ER -
APA
JA, T., L, F., & Committee, E. V. G. E. E. (2001). Closeout of four phase II Vanguard trials and patient rollover into a large international phase III HIV clinical endpoint trial.. Controlled clinical trials. https://doi.org/10.1016/s0197-2456(00)00114-8
Source records
- pubmed · retrieved 2026-09-26T06:17:46.811Z